Controlled trial of dipotassium clorazepate ("Tranxene") in anxiety.
D000293:Adolescent; D000328:Adult; D001007:Anxiety / Q000188:drug therapy*; D001008:Anxiety Disorders / Q000188:drug therapy; D001552:Benzazepines / Q000009:adverse effects / Q000627:therapeutic use*; D002264:Carboxylic Acids / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy; D003975:Diazepam / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012893:Sleep Wake Disorders / Q000139:chemically induced
D001552:Benzazepines; D002264:Carboxylic Acids; D010919:Placebos; D003975:Diazepam